Abstract:Introduction: Inborn errors of immunity (IEI) are a heterogeneous group of disorders characterized by increased risk of infections, autoimmunity, autoinflammatory diseases, malignancy and allergy. Next-generation sequencing has revolutionized the identification of genetic background of these patients and assists in diagnosis and treatment. In this study, we identified a probable unique monogenic cause of IEI, and evaluated the immunological methods and pathogenic detections. Methods: A family with a member with a clinical diagnosis of IEI was screened by whole genomic sequencing (WGS). Demographic data, clinical manifestations, medical history, physical examination, laboratory findings and imaging features of the patient were extracted from medical records. Comprehensive immune monitoring methods include a complete blood count with differential, serum levels of cytokines and autoantibodies, T-cell and B-cell subsets analysis and measurement of serum immunoglobulins. In addition, metagenomic sequencing (mNGS) of blood, cerebrospinal fluid and biopsy from small intestine were used to detect potential pathogens. Results: The patient manifested with recurrent infections and autoimmune disorders, who was eventually diagnosed with IEI. Repetitive mNGS tests of blood, cerebrospinal fluid and biopsy from small intestine didn't detect pathogenic microorganism. Immunological tests showed a slightly decreased level of IgG than normal, elevated levels of tumor necrosis factor and interleukin-6. Lymphocyte flow cytometry showed elevated total B cells and natural killer cells, decreased total T cells and B-cell plasmablasts. WGS of the patient identified a novel heterozygous mutation in IRF2BP2 (c.439_450dup p. Thr147_Pro150dup), which was also confirmed in his father. The mutation was classified as variant of uncertain significance (VUS) according to the American College of Medical Genetics and Genomics guidelines. Conclusion: We identified a novel IRF2BP2 mutation in a family with a member diagnosed with IEI. Immune monitoring and WGS as auxiliary tests are helpful in identifying genetic defects and assisting diagnosis in patients with clinically highly suspected immune abnormalities and deficiencies in inflammation regulation. In addition, mNGS techniques allow a more comprehensive assessment of the pathogenic characteristics of these patients. This report further validates the association of IRF2BP2 deficiency and IEI, and expands IEI phenotypes.

XMEN-associated Systemic EBV-positive T-cell Lymphoma of Childhood: Report of Two Cases and Literature Review

Case Report: EBV-Positive Extra-Nodal Marginal Zone Lymphoma Associated with XMEN Disease Caused by a Novel Hemizygous Mutation in MAGT1

Further Delineation of the Spectrum of XMEN Disease in Six Chinese Pediatric Patients

Case report: XMEN disease: a patient with recurrent Hodgkin lymphoma and immune thrombocytopenia

Identification of a novel MAGT1 mutation supports a diagnosis of XMEN disease

Adult-onset neurodegeneration in XMEN disease

MAGT1 gene mutation causes myositis and CD127 expression downregulation

Epstein-Barr virus infection associated polymyositis and coronary artery dilation

X-linked Hyper-Igm Syndrome with Eosinophilia in a Male Child: A Case Report

HLH and Recurrent EBV Lymphoma as the presenting manifestation of MAGT1 Deficiency: A Systematic Review of the Expanding Disease Spectrum

Preimplantation Genetic Testing for a Chinese Family with X-Linked Lymphoproliferative Syndrome Type 1.

Epigenetic Activation of the TUSC3 Gene As a Potential Therapy for XMEN Disease

Mitochondrial DNA Insert into CD40 Ligand Gene‐associated X‐linked Hyper‐igm Syndrome

A Novel SPECC1L Mutation Causing Teebi Hypertelorism Syndrome: Expanding Phenotypic and Genetic Spectrum

CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes

Epstein-Barr Virus Positive Peripheral T Cell Lymphoma with Novel Variants in STAT5B of a Pediatric Patient: a Case Report

Case Report: A novel IRF2BP2 mutation in an IEI patient with recurrent infections and autoimmune disorders

[Clinical and Pathological Analysis of Three Cases of Childhood Systemic EB Virus Positive T-cell Lymphoproliferative Disease].

Novel Mutation in the Moesin (MSN) Gene Leads to Immunodeficiency with Epstein-Barr Virus (EBV) Infection and Dermatomyositis-Like Symptoms

Demystifying the Mystery of Genes: A Case Report on Constitutional Mismatch Repair Deficiency

Genetic Heterogeneity and Mutational Signature in Chinese Epstein-Barr Virus-Positive Diffuse Large B-cell Lymphoma.